Search
News & Events
Researchers share in almost $3 million for groundbreaking child health researchFive researchers from The Kids Research Institute Australia will share in almost $3 million in grants to continue groundbreaking research to tackle childhood cancer, asthma prevention, lung disease and chronic ear infections.
News & Events
Researchers receive crucial Near Miss fundingCongratulations to four outstanding The Kids Research Institute Australia researchers who have received funding designed to support researchers who have narrowly missed out on highly competitive national funding.
News & Events
Report confirms the economic value of medical research in WAThe Kids Research Institute Australia has welcomed a landmark report which reveals every dollar invested in WA’s medical research sector is more than doubled when it comes to return on investment to our economy.
News & Events
Federal politicians urged to adopt transport priorities that keep kids happy, healthy and safeThe Kids Research Institute Australia has backed a series of transport priorities to keep children safer on the roads, boost physical activity levels, and save the economy billions of dollars.
News & Events
New era for child health research with The Kids Research Institute Australia and Curtin partnership signedThe Kids Research Institute Australia and Curtin University will work together as part of a new agreement focused on enhancing children’s health and medical research in WA.
Research
Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational StudyIn mid-2018, the Australian childhood 13-valent pneumococcal conjugate vaccine schedule changed from 3+0 to 2+1, moving the third dose to 12 months of age, to address increasing breakthrough cases of invasive pneumococcal disease (IPD), predominantly in children aged >12 months. This study assessed the impact of this change using national IPD surveillance data.
Research
The potential of antisense oligonucleotide therapies for inherited childhood lung diseasesAntisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patient's genetic mutation, in particular those lesions that compromise normal pre-mRNA processing. Antisense oligonucleotides can alter gene expression through a variety of mechanisms as determined by the chemistry and antisense oligomer design.
News & Events
The Kids receives critical funding boost from WA GovernmentThe Kids Research Institute Australia is one of 20 West Australian research facilities to share in $25 million funding under the State Government’s Research Infrastructure Support (RIS) program, through the Future Health Research and Innovation (FHRI) Fund.
News & Events
Kids who skip breakfast have poorer NAPLAN results: studyAn Australian study has revealed the clear link between eating breakfast and academic success, with students who skip breakfast some or all of the time achieving poorer NAPLAN results than children who always eat breakfast.
News & Events
Jonathan Carapetis honoured by the Greek communityProfessor Jonathan Carapetis AM, has been recognised as an outstanding member of the Greek diaspora in Australia for his longstanding excellence and leadership within the health and medical research sector.